Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team.

PR Newswire | May 14, 2008 | Copyright

New President/CEO and Executive Chairman Set Sights on Expanding Therapeutic Horizons of Revolutionary Approaches to Adult Stem Cell Biology

BOSTON, SAN DIEGO, SAN FRANCISCO and SEATTLE, May 14 /PRNewswire/ -- Paul A. Grayson and John Mendlein have joined Fate Therapeutics as president and CEO and executive chairman, respectively. Grayson and Mendlein join a team of internationally recognized stem cell scientists, clinicians and investors dedicated to creating best-in-class therapeutics based on a new and proprietary understanding of the role of adult stem cells ...

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

Jonathan Edwards's Writings: Text, Context, Interpretation.(Review)
Magazine article from: The Historian ; ...that Edwards's Nature of True Virtues (1765) invites close comparison with the English philosopher George Berkeley's Alciphron, or the Minute Philosopher (1732), both of which attacked the moral-sense theory of ethics. Wayne Proudfoot concludes...
Private Vices, Publick Benefits: The Contemporary Reception of Bernard Mandeville.
Magazine article from: Philological Quarterly ; ...edition of that work, and his Letter to Dion (1732). In the latter Mandeville responds to Dialogue II in George Berkeley's Alciphron (1732), which Stafford includes in this collection. Among the other selections that had already been reprinted in our...
Hellenistic Commentary to the New Testament
Magazine article from: Journal of the Evangelical Theological Society ; ...many NT scholars read Apuleius, Aristotle, Diogenes Laertius or Epictetus, for example, how many read what remains of Alciphron, Apollodorus, Callimachus or Eunapius? Pace Crossan et al., the NT clearly arose in a distinctively Jewish environment...
George Berkeley: Idealism and the Man.
Magazine article from: The Review of Metaphysics ; ...maneuver, it is important to note that Berkeley consistently expressed hostility to freethinking from his early writings through Alciphron (1732), which was expressly directed against freethinking and contained an explicit attack on the cognitivist semantic...
The Works of George Berkeley, 4 vols. (reprint, 1901).(Brief Article)(Book Review)
Magazine article from: Reference & Research Book News ; ...Vision, A Treatise concerning the Principles of Human Knowledge, Three Dialogues between Hylas and Philonus, De Motu, Alciphron; or, The Minute Philosopher, The Theory of Vision, The Analyst, A Defence of Free-thinking in Mathematics, Arithmetica...
Mariposa sangrienta.(Artículo breve)
Magazine article from: Contenido ; En Filipinas descubrieron una nueva espede de mariposa bautizada Lycaena alciphron parasitus que se alimenta principalmente con sangre de mamferos como musaraas, perros, ornitorrincos y aun seres humanos.
The Rhetoric of Berkeley's Philosophy.
Magazine article from: Philological Quarterly ; ...part survey of Berkeley's major works - The Principles of Human Knowledge, Three Dialogues between Hylas and Philonous, Alciphron, and Siris - opens with an attempt to reclaim ad hominem associations between ethical speakers and philosophical statements...
Art sacre et modernite: Les Grandes Annees de la revue "L'art Sacre."(Brief Article)
Magazine article from: Theological Studies ; ...Ed. D. Efroymson et al. Collegeville: Liturgical, 1993. Pp. 160. $11.95. SYSTEMATIC THEOLOGY Berkeley, G. Alciphron, or the Minute Philosopher in focus. N.Y.: Routledge, 1993 [1732]. Pp. 234. $59.95. Christology in Dialogue...
Philosophy vol. 81, no. 1, January 2006.
Magazine article from: The Review of Metaphysics ; ...clause to be nondefining. John P. Wright's objection to Reid's rejoinder is rebutted. A similarly worded argument in Alciphron avoids confusion since Berkeley denies that things like tables can be said in any unqualified sense to be seen. The Secular...

Find more facts and information related to the article "Fate Therapeutics Taps Successful Biotech CEOs ..."